Recurrence prediction using microRNA expression in hormone receptor positive breast cancer during tamoxifen treatment.

CONCLUSIONS: Distant recurrence during tamoxifen treatment of hormone positive breast cancer might be affected by tamoxifen resistance related miRNAs. Such distant recurrence can be predicted using miRNA measurement. PMID: 30010434 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30010434?dopt=Abstract

Source: Biomarkers - July 18, 2018 Category: Research Tags: Biomarkers Source Type: research